Syntegon sold its former site in Waiblingen to Andreas Stihl AG & Co. KG, moving on with its plans to relocate its production and administration activities to Fellbach and Bad Cannstatt (Stuttgart) this year. The strategy is in view of further growth.

The purchase agreement was signed on March 31. “We are pleased that our long-standing property will be in good hands,” says Torsten Türling, Chief Executive Officer of the Syntegon Group.

Syntegon will establish its central administrative branch in a Business Excellence Center in the Stuttgart district of Bad Cannstatt in the third quarter of 2025. The new offices are close to Stuttgart’s main railway station and airport.

The activities of the Pharma Solid business unit located in Waiblingen will move to a dedicated pharma site in neighboring Fellbach in the second half of 2025.

Türling comments on the relocation: “With the new locations in Fellbach and Bad Cannstatt, we are creating the ideal conditions for further growth and will even better fulfill our role as a strategic technology partner to the global pharmaceutical industry.”

Photo: Syntegon